By: Christopher Parrella, Esq., CPC, CHC, CPCO
Parrella Health Law, Boston, MA.
A Health Care Provider Defense and Compliance Firm.

The Office of Inspector General just issued a favorable advisory opinion that should get the attention of every MSO, urgent care platform and ancillary service operator. The takeaway is simple, but powerful: if there is truly no remuneration tied to referrals, the Anti-Kickback Statute may not be implicated. That sounds obvious. In practice, it is anything but.

This advisory opinion, 26-02, addresses a structure that is increasingly common. An MSO managing multiple urgent care centers wants to expand into laboratory services through an affiliated entity. That is the exact type of arrangement that typically raises immediate Anti-Kickback concerns. Shared ownership, aligned operations and a natural referral stream are usually enough to trigger scrutiny.

Here, however, OIG said no.

The structure itself was not particularly novel. The MSO would own a separate laboratory entity that would perform testing for patients seen at affiliated urgent care centers. The lab would bill payors directly, including federal healthcare programs, and would not bill the clinics. Patients would be informed of the relationship and given a choice to use another lab. Providers could order from multiple labs through the EHR, with no preference given to the affiliated lab.

None of that, standing alone, is enough to get you a favorable opinion. What drove the outcome were the guardrails. OIG focused almost entirely on one issue: whether any remuneration, direct or indirect, flowed in connection with referrals. And the requestor made three critical certifications.

First, provider compensation was not tied in any way to the volume or value of lab services ordered. Second, the lab would not provide any remuneration to the urgent care centers or their providers. Third, no revenue from the lab would be shared back, directly or indirectly, with referral sources. That combination is what mattered. OIG essentially said that if those facts are true, then there is no “remuneration” under the Anti-Kickback Statute, and if there is no remuneration, there is no inducement and if there is no inducement, the statute is not implicated.

That is a very clean framework, and it is one that providers should pay close attention to. But the opinion is just as important for what it warns against.

OIG went out of its way to caution that similar structures will absolutely violate the Anti-Kickback Statute if remuneration is introduced anywhere in the model. And it specifically called out the types of arrangements it continues to see in enforcement actions, including sham consulting agreements, disguised investment opportunities, and the provision of free personnel or equipment.

That last point is critical. Many organizations still underestimate how broadly “remuneration” is defined. It is not just cash. It is anything of value. Free staff, free space, discounted services, or operational support can all qualify if they are tied, even indirectly, to referrals.

That means no referral-based compensation, no revenue sharing, no indirect financial incentives, and no “soft” benefits that could be interpreted as value flowing to the referring provider. It also means preserving real patient choice. In this opinion, patients were informed of the affiliation and given the ability to choose an unaffiliated lab. Providers were not required to use the affiliated lab and were not tracked based on referral patterns. Those facts reinforce the absence of inducement.

There is another practical takeaway here that often gets missed. OIG relied entirely on the facts as certified by the requestor. That means the outcome depends not just on how the arrangement is described, but on how it actually operates. If the real-world implementation deviates from those certifications, the protection of the opinion disappears. The bottom line is this. OIG is not saying integrated models are low risk. It is saying they can be structured in a way that avoids Anti-Kickback exposure if, and only if, remuneration is completely removed from the equation.

If you have any questions or comments about the subject of this blog, please contact Parrella Health Law at 857.328.0382 or Chris directly at cparrella@parrellahealthlaw.com.